PER3 and breast cancer: A comprehensive cohort study of 1,690 breast cancer patients demonstrated a significant association between the genotype variations of PER3 gene and radiotherapy side-effects, suggesting the potential of the PER3 gene as a predictor for radiotherapy response (Webb et al., 2022).